drugset / Trial / NCT05682209

The Effect of Octreotide on Wound Drainage After Mastectomy

NCT05682209

Phase 4 Completed 41 enrolled Ikechukwu Bartholomew Ulasi
RandomizedParallel-groupTriple-blindTreatment

Summary

Patients who had mastectomy for breast cancer usually have drainage of some fluid from the site of surgery. This could be prolonged and may lead to other negative consequences after surgery. Octreotide could potentially reduce the amount of this drainage. In this study, patients were grouped into two: a first group that received octreotide injection and a second group that received a placebo. The study tested whether octreotide injection has any effect on the duration of fluid drainage from the surgery site after mastectomy for breast cancer.

Timeline

Start
2020-12-18
Primary completion
2021-11-15
Completion
2021-12-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Octreotide Peptide 100 ug Intravenous

Indications

No indication recorded.